Compile Data Set for Download or QSAR
maximum 50k data
Found 34 Enz. Inhib. hit(s) with Target = 'Chloroquine resistance transporter'
TargetChloroquine resistance transporter(Plasmodium falciparum)
Oregon Health & Science University

US Patent
LigandPNGBDBM434964(US10584098, Code ELQ-379)
Affinity DataIC50:  2.5nMAssay Description:In vitro experiments show that the intrinsic antiplasmodial activity of ethylcarbonate ester ELQ-337 is indistinguishable from ELQ-300, with IC50 val...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticleUS Patent
TargetChloroquine resistance transporter(Plasmodium falciparum)
Oregon Health & Science University

US Patent
LigandPNGBDBM434955(US10584098, Code ELQ-337)
Affinity DataIC50:  2.5nMAssay Description:In vitro experiments show that the intrinsic antiplasmodial activity of ethylcarbonate ester ELQ-337 is indistinguishable from ELQ-300, with IC50 val...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticleUS Patent
TargetChloroquine resistance transporter(Plasmodium falciparum)
Oregon Health & Science University

US Patent
LigandPNGBDBM434960(US10584098, Code ELQ-359)
Affinity DataIC50:  2.5nMAssay Description:In vitro experiments show that the intrinsic antiplasmodial activity of ethylcarbonate ester ELQ-337 is indistinguishable from ELQ-300, with IC50 val...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticleUS Patent
TargetChloroquine resistance transporter(Plasmodium falciparum)
Oregon Health & Science University

US Patent
LigandPNGBDBM434954(US10584098, Code ELQ-336)
Affinity DataIC50:  2.5nMAssay Description:In vitro experiments show that the intrinsic antiplasmodial activity of ethylcarbonate ester ELQ-337 is indistinguishable from ELQ-300, with IC50 val...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticleUS Patent
TargetChloroquine resistance transporter(Plasmodium falciparum)
Oregon Health & Science University

US Patent
LigandPNGBDBM434962(US10584098, Code ELQ-374)
Affinity DataIC50:  2.70nMAssay Description:In vitro experiments show that the intrinsic antiplasmodial activity of ethylcarbonate ester ELQ-337 is indistinguishable from ELQ-300, with IC50 val...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticleUS Patent
TargetChloroquine resistance transporter(Plasmodium falciparum)
Oregon Health & Science University

US Patent
LigandPNGBDBM434956(US10584098, Code ELQ-354)
Affinity DataIC50:  3nMAssay Description:In vitro experiments show that the intrinsic antiplasmodial activity of ethylcarbonate ester ELQ-337 is indistinguishable from ELQ-300, with IC50 val...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticleUS Patent
TargetChloroquine resistance transporter(Plasmodium falciparum)
Oregon Health & Science University

US Patent
LigandPNGBDBM434953(US10584098, Code ELQ-300)
Affinity DataIC50:  3.10nMAssay Description:In vitro experiments show that the intrinsic antiplasmodial activity of ethylcarbonate ester ELQ-337 is indistinguishable from ELQ-300, with IC50 val...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticleUS Patent
TargetChloroquine resistance transporter(Plasmodium falciparum)
Oregon Health & Science University

US Patent
LigandPNGBDBM434961(US10584098, Code ELQ-373)
Affinity DataIC50:  3.10nMAssay Description:In vitro experiments show that the intrinsic antiplasmodial activity of ethylcarbonate ester ELQ-337 is indistinguishable from ELQ-300, with IC50 val...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticleUS Patent
TargetChloroquine resistance transporter(Plasmodium falciparum)
Oregon Health & Science University

US Patent
LigandPNGBDBM434958(US10584098, Code ELQ-357)
Affinity DataIC50:  3.5nMAssay Description:In vitro experiments show that the intrinsic antiplasmodial activity of ethylcarbonate ester ELQ-337 is indistinguishable from ELQ-300, with IC50 val...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticleUS Patent
TargetChloroquine resistance transporter(Plasmodium falciparum)
Oregon Health & Science University

US Patent
LigandPNGBDBM434957(US10584098, Code ELQ-355)
Affinity DataIC50:  3.90nMAssay Description:In vitro experiments show that the intrinsic antiplasmodial activity of ethylcarbonate ester ELQ-337 is indistinguishable from ELQ-300, with IC50 val...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticleUS Patent
TargetChloroquine resistance transporter(Plasmodium falciparum)
Oregon Health & Science University

US Patent
LigandPNGBDBM434959(US10584098, Code ELQ-358)
Affinity DataIC50:  6nMAssay Description:In vitro experiments show that the intrinsic antiplasmodial activity of ethylcarbonate ester ELQ-337 is indistinguishable from ELQ-300, with IC50 val...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticleUS Patent
TargetChloroquine resistance transporter(Plasmodium falciparum)
Oregon Health & Science University

US Patent
LigandPNGBDBM434963(US10584098, Code ELQ-375)
Affinity DataIC50:  8.20nMAssay Description:In vitro experiments show that the intrinsic antiplasmodial activity of ethylcarbonate ester ELQ-337 is indistinguishable from ELQ-300, with IC50 val...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticleUS Patent
TargetChloroquine resistance transporter(Plasmodium falciparum)
Oregon Health & Science University

US Patent
LigandPNGBDBM50396334(CHEMBL2170034)
Affinity DataIC50:  1.03E+4nMAssay Description:Inhibition of chloroquine-resistant Plasmodium falciparum Dd2 CRT expressed in Xenopus laevis oocyte assessed as inhibition of [3H]chloroquine uptake...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetChloroquine resistance transporter(Plasmodium falciparum)
Oregon Health & Science University

US Patent
LigandPNGBDBM50396333(CHEMBL2170036)
Affinity DataIC50:  1.05E+4nMAssay Description:Inhibition of chloroquine-resistant Plasmodium falciparum Dd2 CRT expressed in Xenopus laevis oocyte assessed as inhibition of [3H]chloroquine uptake...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetChloroquine resistance transporter(Plasmodium falciparum)
Oregon Health & Science University

US Patent
LigandPNGBDBM50563441(CHEMBL4745810)
Affinity DataIC50:  1.25E+4nMAssay Description:Inhibition of Plasmodium falciparum Dd2 CRT expressed in Xenopus laevis oocyte assessed as inhibition of [3H]-CQ transport incubated for 1.5 hrs by m...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
TargetChloroquine resistance transporter(Plasmodium falciparum)
Oregon Health & Science University

US Patent
LigandPNGBDBM519((2S)-N-[(2S,3R)-4-[(3S,4aS,8aS)-3-(tert-butylcarba...)
Affinity DataIC50:  1.30E+4nMAssay Description:Inhibition of chloroquine-resistant Plasmodium falciparum Dd2 CRT expressed in Xenopus laevis oocyte assessed as inhibition of [3H]chloroquine uptake...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetChloroquine resistance transporter(Plasmodium falciparum)
Oregon Health & Science University

US Patent
LigandPNGBDBM519((2S)-N-[(2S,3R)-4-[(3S,4aS,8aS)-3-(tert-butylcarba...)
Affinity DataIC50:  1.30E+4nMAssay Description:Inhibition of chloroquine-resistant Plasmodium falciparum Dd2 CRT expressed in Xenopus laevis oocytes assessed as reduction in [3H]-chloroquine uptak...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetChloroquine resistance transporter(Plasmodium falciparum)
Oregon Health & Science University

US Patent
LigandPNGBDBM50563442(CHEMBL4754685)
Affinity DataIC50:  1.56E+4nMAssay Description:Inhibition of Plasmodium falciparum Dd2 CRT expressed in Xenopus laevis oocyte assessed as inhibition of [3H]-CQ transport incubated for 1.5 hrs by m...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
TargetChloroquine resistance transporter(Plasmodium falciparum)
Oregon Health & Science University

US Patent
LigandPNGBDBM50338982((R)-5-((3,4-dimethoxyphenethyl)(methyl)amino)-2-(3...)
Affinity DataIC50:  3.00E+4nMAssay Description:Inhibition of chloroquine-resistant Plasmodium falciparum Dd2 CRT expressed in Xenopus laevis oocytes assessed as reduction in [3H]-chloroquine uptak...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetChloroquine resistance transporter(Plasmodium falciparum)
Oregon Health & Science University

US Patent
LigandPNGBDBM50338982((R)-5-((3,4-dimethoxyphenethyl)(methyl)amino)-2-(3...)
Affinity DataIC50:  3.00E+4nMAssay Description:Inhibition of chloroquine-resistant Plasmodium falciparum Dd2 CRT expressed in Xenopus laevis oocyte assessed as inhibition of [3H]chloroquine uptake...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetChloroquine resistance transporter(Plasmodium falciparum)
Oregon Health & Science University

US Patent
LigandPNGBDBM81939(CAS_52-53-9 | NSC_62969 | VERAPAMIL)
Affinity DataIC50:  3.30E+4nMAssay Description:Inhibition of chloroquine-resistant Plasmodium falciparum Dd2 CRT expressed in Xenopus laevis oocytes plasma membrane assessed as reduction of [3H]-c...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetChloroquine resistance transporter(Plasmodium falciparum)
Oregon Health & Science University

US Patent
LigandPNGBDBM50353744(CHEMBL1830986)
Affinity DataIC50:  3.60E+4nMAssay Description:Inhibition of chloroquine-resistant Plasmodium falciparum Dd2 chloroquine resistance transporter expressed in xenopus laevis oocytes assessed as inhi...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetChloroquine resistance transporter(Plasmodium falciparum)
Oregon Health & Science University

US Patent
LigandPNGBDBM35938(1-(p-chlorophenyl)-1-(2-pyridyl)-3-N,N-dimethylpro...)
Affinity DataIC50:  5.40E+4nMAssay Description:Inhibition of chloroquine-resistant Plasmodium falciparum Dd2 CRT expressed in Xenopus laevis oocytes plasma membrane assessed as reduction of [3H]-c...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetChloroquine resistance transporter(Plasmodium falciparum)
Oregon Health & Science University

US Patent
LigandPNGBDBM50563440(CHEMBL4784051)
Affinity DataIC50:  5.50E+4nMAssay Description:Inhibition of Plasmodium falciparum Dd2 CRT expressed in Xenopus laevis oocyte assessed as inhibition of [3H]-CQ transport incubated for 1.5 hrs by m...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
TargetChloroquine resistance transporter(Plasmodium falciparum)
Oregon Health & Science University

US Patent
LigandPNGBDBM50353743(CHEMBL1830985)
Affinity DataIC50:  5.80E+4nMAssay Description:Inhibition of chloroquine-resistant Plasmodium falciparum Dd2 chloroquine resistance transporter expressed in xenopus laevis oocytes assessed as inhi...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetChloroquine resistance transporter(Plasmodium falciparum)
Oregon Health & Science University

US Patent
LigandPNGBDBM50020157(CHEMBL3288457)
Affinity DataIC50:  6.30E+4nMAssay Description:Inhibition of chloroquine-resistant Plasmodium falciparum Dd2 CRT expressed in Xenopus laevis oocytes plasma membrane assessed as reduction of [3H]-c...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetChloroquine resistance transporter(Plasmodium falciparum)
Oregon Health & Science University

US Patent
LigandPNGBDBM50563439(CHEMBL4748649)
Affinity DataIC50:  6.40E+4nMAssay Description:Inhibition of Plasmodium falciparum Dd2 CRT expressed in Xenopus laevis oocyte assessed as inhibition of [3H]-CQ transport incubated for 1.5 hrs by m...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
TargetChloroquine resistance transporter(Plasmodium falciparum)
Oregon Health & Science University

US Patent
LigandPNGBDBM50020159(CHEMBL3286418)
Affinity DataIC50:  6.60E+4nMAssay Description:Inhibition of chloroquine-resistant Plasmodium falciparum Dd2 CRT expressed in Xenopus laevis oocytes plasma membrane assessed as reduction of [3H]-c...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetChloroquine resistance transporter(Plasmodium falciparum)
Oregon Health & Science University

US Patent
LigandPNGBDBM71542((4-amino-1-methyl-butyl)-(6-methoxy-8-quinolyl)ami...)
Affinity DataIC50:  6.80E+4nMAssay Description:Inhibition of chloroquine-resistant Plasmodium falciparum Dd2 CRT expressed in Xenopus laevis oocytes plasma membrane assessed as reduction of [3H]-c...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetChloroquine resistance transporter(Plasmodium falciparum)
Oregon Health & Science University

US Patent
LigandPNGBDBM50353745(CHEMBL1830987)
Affinity DataIC50:  6.90E+4nMAssay Description:Inhibition of chloroquine-resistant Plasmodium falciparum Dd2 chloroquine resistance transporter expressed in xenopus laevis oocytes assessed as inhi...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetChloroquine resistance transporter(Plasmodium falciparum)
Oregon Health & Science University

US Patent
LigandPNGBDBM50017696((2-dimethylamino-2-methyl)ethyl-N-dibenzoparathiaz...)
Affinity DataIC50:  8.50E+4nMAssay Description:Inhibition of chloroquine-resistant Plasmodium falciparum Dd2 CRT expressed in Xenopus laevis oocytes plasma membrane assessed as reduction of [3H]-c...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetChloroquine resistance transporter(Plasmodium falciparum)
Oregon Health & Science University

US Patent
LigandPNGBDBM50020160(CHEMBL3288467)
Affinity DataIC50:  1.80E+5nMAssay Description:Inhibition of chloroquine-resistant Plasmodium falciparum Dd2 CRT expressed in Xenopus laevis oocytes plasma membrane assessed as reduction of [3H]-c...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetChloroquine resistance transporter(Plasmodium falciparum)
Oregon Health & Science University

US Patent
LigandPNGBDBM50399930(CHEMBL2181208)
Affinity DataIC50:  2.28E+5nMAssay Description:Inhibition of chloroquine-resistant Plasmodium falciparum Dd2 CRT expressed in Xenopus laevis oocytes assessed as reduction in [3H]-chloroquine uptak...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetChloroquine resistance transporter(Plasmodium falciparum)
Oregon Health & Science University

US Patent
LigandPNGBDBM50020154(CHEMBL3288452)
Affinity DataIC50:  3.21E+5nMAssay Description:Inhibition of chloroquine-resistant Plasmodium falciparum Dd2 CRT expressed in Xenopus laevis oocytes plasma membrane assessed as reduction of [3H]-c...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed